A Randomized Controlled Trial Comparing Botulinum Toxin Type A Xeomin (R) and Dysport (R) for Treatment Of Primary Axillary Hyperhidrosis (P3.021)

CONCLUSIONSBoth AbobotulinumtoxinA and IncobotulinumtoxinA are safe and effective in the treatment of axillary hyperhidrosis. The different effectiveness of the two toxins documented by HDSS score may be related to underdosage or excessive dilution of Incobotulinum toxin: a new study in other 20 patients with axillary hyperhidrosis is ongoing, which compares IncobotulinumtoxinA, 100UI and AbobotulinumtoxinA, 250UI per axilla.Disclosure: Dr. Pastorelli has nothing to disclose. Dr. Michelucci has nothing to disclose. Dr. Plasmati has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: General Neurology II Source Type: research